Product Description
EYLEA 40mg Injection is a rarefied, elite option for managing serious retinal vascular diseases such as wet age-related macular degeneration, diabetic macular edema, and macular edema from retinal vein occlusion. Each single-use vial or pre-filled syringe is engineered for optimum efficacy, containing the prodigious Aflibercept 40mg. This scarce, cost-effective therapy is offered as a prescription-only intravitreal injection, ensuring targeted results under medical expertise. The clear, colorless to pale yellow solution maintains sterility and safety in a secure, manufacturer-sealed carton. Exclusively for hospital and clinic use in India, it promises uncompromising quality for discerning healthcare professionals.
Precise Administration & Safe Usage
Eylea 40mg Injection is strictly for intravitreal (ophthalmic) use, administered by qualified healthcare professionals. As a prescription-only medicine, it is reserved for elite clinical application within hospital and clinic environments. Direction of use ensures optimum safety: the injection is given directly into the eye by a skilled practitioner to maximize therapeutic benefit and minimize risk. Patients should not attempt to self-administer or use outside supervised medical settings.
Sample Access, Policy Assurance, & Supply Terms
Eylea 40mg Injection samples are available to qualified healthcare facilities. Our sample policy is guided by ethical standards and regulatory compliance. Supply ability meets institutional requirements, ensuring both consistent availability and fulfillment of bulk orders across India. The sale price, asking rate, and export pricing are transparently communicated to all partners. Each transaction is designed for efficiency and reliability, supporting patient access to this elite and scarce therapy.
FAQ's of Eylea 40mg Injection:
Q: How should Eylea 40mg Injection be administered?
A: Eylea 40mg Injection must be administered via intravitreal injection directly into the eye by a medical professional in a qualified clinical or hospital setting.
Q: What conditions does Eylea 40mg Injection treat?
A: Eylea is indicated for the treatment of wet age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, and other retinal vascular disorders.
Q: When can I obtain Eylea 40mg Injection?
A: Eylea is provided to healthcare facilities upon prescription and is not available for over-the-counter purchase. Only authorized clinics and hospitals can acquire and administer the injection.
Q: Where must Eylea be stored after purchase?
A: Eylea 40mg Injection should be stored in a refrigerator at 2C to 8C and must not be frozen. It should remain in its manufacturer-sealed carton until use.
Q: What is the recommended process for handling and using Eylea samples?
A: Sample use is limited to hospital and clinic environments under professional supervision. Each sample follows strict policy guidelines to ensure patient safety and compliance with regulatory standards.
Q: What are the key benefits of choosing Eylea 40mg Injection?
A: Eylea offers elite efficacy in retinal disease management with a cost-effective, sterile formulation, supporting optimum patient outcomes in healthcare settings.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese